Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum creatinine changes in cervical cancer patients receiving concurrent chemoradiation: IV versus oral post‑hydration
TCTR20250920001Phase 3Completed
- Sponsor
- Songklanagarind Hospital
- Start
- Jan 2016
- Countries
- 1
01
Overview
Phase 3, randomised trial in Cervical Cancer (CC) (2 arms), sponsored by Songklanagarind Hospital. Primary endpoint: Change in serum creatinine. Started Jan 2016; status: completed.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on TCTR20250920001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250920001.